Skip to main content
. Author manuscript; available in PMC: 2018 Nov 15.
Published in final edited form as: Eur J Pharm Sci. 2017 Aug 1;109:78–85. doi: 10.1016/j.ejps.2017.07.031

Figure 3. Experiment 2, GET 73 repeated dose administration.

Figure 3

A dose-related increase in mean maximum plasma drug concentration was observed on Day 14 (336 hours) and the median maximum plasma drug concentration occurred between 0.5 – 2.05 hours in all groups on Day 14 (336 hours). Total exposure also increased with an increase in GET 73 dose. Results are reported as M ± SEM.